<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ozempic - Diplomacy &amp; Trade</title>
	<atom:link href="https://dteurope.com/tag/ozempic/feed/" rel="self" type="application/rss+xml" />
	<link>https://dteurope.com</link>
	<description>Monthly in print &#124; Daily on the web</description>
	<lastBuildDate>Thu, 11 Jun 2026 15:11:01 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://dteurope.com/wp-content/uploads/cropped-dt_favicon-32x32.png</url>
	<title>ozempic - Diplomacy &amp; Trade</title>
	<link>https://dteurope.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Richter, Hetero Labs Partner on Generic of Ozempic</title>
		<link>https://dteurope.com/business/richter-hetero-labs-partner-on-generic-of-ozempic/</link>
		
		<dc:creator><![CDATA[D&#38;T]]></dc:creator>
		<pubDate>Wed, 10 Jun 2026 09:18:00 +0000</pubDate>
				<category><![CDATA[Business]]></category>
		<category><![CDATA[gedeonrichter]]></category>
		<category><![CDATA[heterolab]]></category>
		<category><![CDATA[ozempic]]></category>
		<category><![CDATA[pharmaceuticalindustry]]></category>
		<guid isPermaLink="false">https://dteurope.com/?p=80198</guid>

					<description><![CDATA[<p>Hungarian pharmaceutical company Gedeon Richter announced the signing of a global collaboration agreement with Indian peer Hetero Labs on the joint development, registration and commercialization of a semaglutide injection, a generic of the anti-diabetic drug Ozempic, the Hungarian company has announced on thew website of the Budapest Stock Exchange. The agreement combines the companies’ complementary [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://dteurope.com/business/richter-hetero-labs-partner-on-generic-of-ozempic/">Richter, Hetero Labs Partner on Generic of Ozempic</a> appeared first on <a rel="nofollow" href="https://dteurope.com">Diplomacy &amp; Trade</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
